Cargando…
Advancements in Sickle Cell Disease (SCD) Treatment: A Review of Novel Pharmacotherapies and Their Impact on Patient Outcomes
Sickle cell disease (SCD) is a genetic hereditary blood disease that disrupts normal beta-globin production. Patients with SCD experience a broad range of symptoms ranging from anemia, pain crises, and jaundice to acute coronary syndrome and stroke. SCD has been treated with hydroxyurea since 1998. ...
Autores principales: | Khan, Salman J, Zaidi, Syed Asjad Tauheed, Murtaza, Syeda Fatima, Asif, Muhammad, Kumar, Vinod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472971/ https://www.ncbi.nlm.nih.gov/pubmed/37664319 http://dx.doi.org/10.7759/cureus.42847 |
Ejemplares similares
-
A Rare Presentation of Colon Carcinoma Metastasis Within a Meningioma: A Case Report and Literature Review
por: Khan, Salman J, et al.
Publicado: (2023) -
Type 1 Diabetes Mellitus Management and Islet Cell Therapy: A New Chapter in Patient Care
por: Alam, Sadaf, et al.
Publicado: (2023) -
Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency
por: Saxena, Parima, et al.
Publicado: (2023) -
Effect of Acetazolamide as Add-On Diuretic Therapy in Patients With Heart Failure: A Meta-Analysis
por: Malik, Bilal Aziz, et al.
Publicado: (2023) -
From Symptomatic Treatment to Disease Modification: A Turning Point in Alzheimer’s Disease Management
por: Sheikh, Mahtab, et al.
Publicado: (2023)